Flyte Therapy
Flyte is an FDA-cleared, non-invasive, at-home intravaginal device designed to treat stress urinary incontinence (SUI) by strengthening weak pelvic floor muscles.
It utilizes mechanotherapy—gentle mechanical vibrations—to enhance the effectiveness of pelvic floor exercises, amplifying muscle contractions up to 39 times more than Kegels alone
HSA/FSA Eligible
The Flyte device is HSA/FSA eligible.
Flyte® has undergone two significant clinical studies evaluating its effectiveness in treating stress urinary incontinence (SUI):
Norwegian Study: This study involved 60 women with SUI who had previously undergone unsuccessful conservative treatments and were considered for surgery. After using Flyte for 5 minutes daily over 6 weeks, 82% of participants achieved continence. A two-year follow-up indicated that 77% of these women maintained continence without requiring surgical intervention.
U.S. Study: Conducted with 119 women, including those with severe SUI (experiencing over 500 grams of leakage in 24 hours), this randomized, controlled, double-blind trial demonstrated that 71% of participants became dry or near dry within 2 to 12 weeks of Flyte use. Significant improvements were also observed in SUI symptoms and overall quality of life.
Learn more here.
Research